Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vitae Pharmaceuticals VTAE

Healthcare Biotechnology
"Vitae Pharmaceuticals Inc is a clinical stage biotechnology company focused on discovering and developing novel, small molecule drugs for diseases where there are unmet medical needs."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VTAE)

Research Reports Coverage on Biotech Stocks -- Radius Health, Vitae Pharma, Global Blood Therapeutics, and Cambrex

PR Newswire October 26, 2016

Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae

PR Newswire October 17, 2016

VITAE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vitae Pharmaceuticals, Inc. (VTAE) Over the Proposed Sale of the Company to Allergan plc

PR Newswire September 23, 2016

More Pharma Deals In The Pipeline?

Benzinga.com  September 21, 2016

Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma

Benzinga.com  September 21, 2016

Watch These 6 Huge Call Purchases In Friday Trade

Benzinga.com  September 16, 2016

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

Business Wire September 15, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceuticals, Inc. to Allergan plc for $21.00 Per Share

Business Wire September 15, 2016

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

Business Wire September 14, 2016
View More News ››

Opinion & Analysis (NDAQ:VTAE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VTAE)

Company description looks exactly like another outfit I used

to have called Lorus now Aptose which went nowhere for 30 years....best to anyone here
ardbegoil - May 22, 2019
View more Bullboard ››

Westhaven Gold Corp.

Westhaven Gold Corp.

Westhaven Gold Corp. is a Canada-based gold-focused exploration company. The Company is advancing the high-grade discovery on ...
View More »